Would Steroids Be Approved for Clinical Use Today?
Despite their seemingly miraculous efficacy, the long-term adverse effects of glucocorticoids pose significant challenges. This reality led Ali A. Habib, MD and Pushpa Narayanaswami, MD to author an ...
In Conversation With… Glenn Philips, PhD
“We're using the same tools that demonstrate the benefit of our drugs to show that the long-term cost of steroids has been vastly underestimated.” Glenn Philips, PhD is the Vice President of Health ...
Quantifying the Risk-Benefit Ratio of Steroids in Myasthenia Gravis
A pioneering analysis of electronic health record (EHR) data from the Optum® EHR database has shown that it is finally possible to quantify the risk-to-benefit ratio of prescribing glucocorticoids, ...
Discovering Steroid-toxicity Secrets Concealed in Large Datasets
A challenge that has vexed health systems and payers for decades is the inability to fully quantify the long-term impacts of steroid-toxicity. Set to change that paradigm is the GTI-MD, an ...
75 Years of Steroid-Toxicity
On September 4, 1948, the first dose of a glucocorticoid was administered to a bed-ridden 24-year-old woman with rheumatoid arthritis. The treatment of rheumatoid arthritis with cortisone resulted in ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
